Breaking News Instant updates and real-time market news.

MDRX

Allscripts

, CERN

Cerner

$66.04

0.11 (0.17%)

06:01
06/19/17
06/19
06:01
06/19/17
06:01

Allscripts downgraded to Market Perform from Outperform at Leerink

Leerink analyst David Larsen downgraded Allscripts (MDRX) to Market Perform and lowered his price target for the shares to $13 from $15. The analyst sees "significant attrition risk" to the company's Sunrise base as his channel checks indicate Cerner (CERN) and Epic are winning the vast majority of share. Further, the Republican healthcare bill "may put even more pressure on hospital budgets," Larsen tells investors in a research note.

MDRX

Allscripts

CERN

Cerner

$66.04

0.11 (0.17%)

  • 21

    Jun

MDRX Allscripts

03/27/17
OPCO
03/27/17
NO CHANGE
OPCO
ACHA defeat removes concerns on hospital spending names, says Oppenheimer
After House Speaker Paul Ryan pulled the American Health Care Act amid lack of support, Oppenheimer analyst Mohan Naidu points out that the Republican rhetoric post-defeat suggests that they are likely to leave Affordable Care Act alone for now and move forward to the next agenda. The analyst believes this could provide some relief and remove concerns on hospital spending names such as Cerner (CERN), Allscripts (MDRX), Omnicell (OMCL) and Vocera (VCRA). Additionally, Naidu notes that concerns on HMS Holdings' (HMSY) Medicaid business should also ease up and move the stock higher. HealthEquity (HQY) is likely to be under pressure, but the new administration will likely push pro-HSA legislation via other avenues as well as through regulation changes, he adds, saying he would buy HealthEquity on any pullback.
05/15/17
BOFA
05/15/17
INITIATION
Target $14
BOFA
Neutral
Allscripts initiated with a Neutral at BofA/Merrill
BofA/Merrill initiated Allscripts with a Neutral and a $14 price target.
05/15/17
05/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Jazz Pharmaceuticals (JAZZ) initiated with an Outperform at RBC Capital. 2. Visteon (VC) initiated with a Sector Perform at RBC Capital. 3. Allscripts (MDRX) initiated with a Neutral at BofA/Merrill. 4. Independent Bank (INDB) initiated with a Neutral at Piper Jaffray. 5. Karyopharm (KPTI) initiated with an Overweight at Cantor. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/25/17
JEFF
05/25/17
NO CHANGE
JEFF
After hospital survey, Jefferies says buy Allscripts and Cerner
Jefferies analyst Sean Dodge says his survey of hospital executives indicates the pace of bookings growth for EHR vendors will continue uninterrupted despite the political uncertainty overhanging the space. Concerns of a slowdown are weighing on valuations, Dodge tells investors in a research note. He likes shares of Allscripts (MDRX) and Cerner (CERN) for their "integrated platforms and exposure to the hospital market." The analyst recommends buying both stocks.
CERN Cerner
$66.04

0.11 (0.17%)

06/05/17
06/05/17
NO CHANGE
Target $69

Overweight
VA contract largely priced into Cerner shares, says Piper Jaffray
Piper Jaffray analyst Sean Wieland believes the expectation of today's Veterans Affairs contract was largely priced into the Cerner with the stock up only 1% on the news. The analyst, while noting the contract still needs to be negotiated, believes Cerner was the obvious choice with the Department of Defense already running Millenium. He reiterates an Overweight rating on the shares with a $69 price target.
06/05/17
BOFA
06/05/17
NO CHANGE
Target $71
BOFA
Buy
Cerner price target raised to $71 from $66 at BofA/Merrill
06/06/17
SBSH
06/06/17
NO CHANGE
Target $60
SBSH
Buy
Veterans Affairs decision may be good for Leidos, says Citi
Citi analyst Jonathan Raviv believes the Department of Veterans Affairs' announcement yesterday that it will adopt the same core for its Electronic Health Record system as used at the Department of Defense may be good news for Leidos (LDOS). Leidos is the lead integrator on the Department of Defense implementation, which uses Cerner's (CERN) Millennium product, Raviv tells investors in a research note. The analyst keeps a Buy rating on Leidos with a $60 price target.
06/06/17
JPMS
06/06/17
NO CHANGE
Target $72
JPMS
Overweight
Cerner price target raised to $72 from $65 at JPMorgan
JPMorgan analyst Lisa Gill raised her price target for Cerner to $72 after the Department of Veteran Affairs announced its intent to use the company's Millennium platform as its Electronic Health Record system replacement. Assuming Cerner is able to secure a prime contractor role, the economics could be seven-to-14 times the size of the Department of Defense contract win, Gill tells investors in a research note. She sees the contract as creating a "longer term tail to growth" and keeps an Overweight rating on Cerner.

TODAY'S FREE FLY STORIES

FB

Facebook

$179.80

2.2 (1.24%)

, AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

14:08
01/19/18
01/19
14:08
01/19/18
14:08
Periodicals
Facebook not bidding for Thursday Night Football rights, Bloomberg reports »

Facebook (FB) has decided…

FB

Facebook

$179.80

2.2 (1.24%)

AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

HPQ

HP Inc.

$23.62

0.33 (1.42%)

14:06
01/19/18
01/19
14:06
01/19/18
14:06
Conference/Events
HP Inc. to hold a webcast »

Global Head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 22

    Jan

RENN

Renren

$10.96

-0.16 (-1.44%)

14:05
01/19/18
01/19
14:05
01/19/18
14:05
Options
Renren call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$3.66

0.03 (0.83%)

14:04
01/19/18
01/19
14:04
01/19/18
14:04
Hot Stocks
Tonix: Horsepox virus showed protection vs. lethal vaccinia infection in study »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$587.11

7.89 (1.36%)

, CIR

Circor

$53.40

1.12 (2.14%)

14:04
01/19/18
01/19
14:04
01/19/18
14:04
Hot Stocks
BlackRock reports 12.6% passive stake in Circor »

In a regulatory filing,…

BLK

BlackRock

$587.11

7.89 (1.36%)

CIR

Circor

$53.40

1.12 (2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 22

    Feb

VIA

Viacom

$39.70

1.85 (4.89%)

, FOXA

21st Century Fox

$36.18

-0.93 (-2.51%)

14:04
01/19/18
01/19
14:04
01/19/18
14:04
Hot Stocks
Box Office Battle: 'Jumanji,' 'The Post' expected to hold off '12 Strong' »

Still expected to remain…

VIA

Viacom

$39.70

1.85 (4.89%)

FOXA

21st Century Fox

$36.18

-0.93 (-2.51%)

LGF.B

Lionsgate

$33.25

0.41 (1.25%)

VIAB

Viacom

$33.95

1.99 (6.23%)

CMCSA

Comcast

$41.85

0.17 (0.41%)

CMCSK

Comcast

LGF.A

Lionsgate

$35.22

0.72 (2.09%)

TWX

Time Warner

$92.90

-0.07 (-0.08%)

DIS

Disney

$110.18

-0.24 (-0.22%)

SNE

Sony

$49.80

0.63 (1.28%)

FOX

21st Century Fox

$35.73

-0.76 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

BLK

BlackRock

$586.98

7.76 (1.34%)

, BXS

BancorpSouth

$34.90

0.35 (1.01%)

14:02
01/19/18
01/19
14:02
01/19/18
14:02
Hot Stocks
BlackRock reports 10.2% passive stake in BancorpSouth »

In a regulatory filing,…

BLK

BlackRock

$586.98

7.76 (1.34%)

BXS

BancorpSouth

$34.90

0.35 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 25

    Jan

14:00
01/19/18
01/19
14:00
01/19/18
14:00
General news
Action Economics Survey results: »

Action Economics Survey…

BASFY

BASF

$29.54

0.825 (2.87%)

, BAYRY

Bayer

$31.82

0.015 (0.05%)

13:57
01/19/18
01/19
13:57
01/19/18
13:57
Periodicals
Breaking Periodicals news story on BASF, Bayer »

Capitol Forum says BASF,…

BASFY

BASF

$29.54

0.825 (2.87%)

BAYRY

Bayer

$31.82

0.015 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 25

    Mar

13:55
01/19/18
01/19
13:55
01/19/18
13:55
General news
SF Fed moderate Williams said economic tailwinds »

SF Fed moderate Williams…

OCPNY

Olympus Corp

$38.27

-0.12 (-0.31%)

13:54
01/19/18
01/19
13:54
01/19/18
13:54
Hot Stocks
Judge grants new trial for Bigler Family vs. Olympus wrongful-death case »

A King County court has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$77.99

0.6 (0.78%)

13:52
01/19/18
01/19
13:52
01/19/18
13:52
Periodicals
Citi plans to have post-Brexit trading hub running by year end, Bloomberg says »

Citigroup intends to have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 24

    Jan

CANF

Can-Fite BioPharma

$1.76

0.01 (0.57%)

13:50
01/19/18
01/19
13:50
01/19/18
13:50
Conference/Events
Can-Fite BioPharma participates in lunch meeting with Philadelphia Securities »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

13:50
01/19/18
01/19
13:50
01/19/18
13:50
Options
VIX slips on a relatively quiet monthly expiration »

VIX slips on a relatively…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:50
01/19/18
01/19
13:50
01/19/18
13:50
General news
Oil Action: Baker-Hughes »

Oil Action: Baker-Hughes…

KMI

Kinder Morgan

$18.97

-0.045 (-0.24%)

13:45
01/19/18
01/19
13:45
01/19/18
13:45
Options
Post earnings premium seller collects $13M in KinderMorgan »

Post earnings premium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$91.92

1.61 (1.78%)

13:45
01/19/18
01/19
13:45
01/19/18
13:45
Options
Incyte call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

PRQR

ProQR Therapeutics

13:31
01/19/18
01/19
13:31
01/19/18
13:31
Conference/Events
ProQR Therapeutics to h old an investor event »

Investor Event will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

CMC

Commercial Metals

$24.83

-0.26 (-1.04%)

13:30
01/19/18
01/19
13:30
01/19/18
13:30
Options
Second day of call buying in Commercial Metals »

Second day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLEX

Flex

$19.61

0.17 (0.87%)

13:25
01/19/18
01/19
13:25
01/19/18
13:25
Options
Flex call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

CSCO

Cisco

$41.30

0.1 (0.24%)

13:22
01/19/18
01/19
13:22
01/19/18
13:22
Periodicals
Cisco expands Spectre, Meltdown investigation to nine more products, CRN reports »

Cisco added nine more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHS

Universal Health

$119.50

2.18 (1.86%)

13:21
01/19/18
01/19
13:21
01/19/18
13:21
Periodicals
Chronicle review shows Universal Health hospital failed to watch patients »

Universal Health's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.26

0.16 (0.09%)

, AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

13:20
01/19/18
01/19
13:20
01/19/18
13:20
Periodicals
Spotify to offer news, political coverage to lure listeners, Bloomberg says »

Spotify will begin…

AAPL

Apple

$179.26

0.16 (0.09%)

AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

GOOG

Alphabet

$1,129.79

-2.19 (-0.19%)

GOOGL

Alphabet Class A

$1,135.97

-3.13 (-0.27%)

SIRI

SiriusXM

$5.47

0.03 (0.55%)

P

Pandora

$4.49

-0.005 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

$NSD

NASDAQ Market Internals

13:17
01/19/18
01/19
13:17
01/19/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETS

PetMed Express

$50.57

-0.31 (-0.61%)

13:16
01/19/18
01/19
13:16
01/19/18
13:16
Technical Analysis
Technical Earnings Preview: PetMed Express at life highs before news »

The stock is at life…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.